Alba prioritises its female employees’ well-being with a month-long Breast Cancer Awareness Campaign

Image Source: albasmelter.com
WT default author logo
Women's Tabloid News Desk

Aluminium Bahrain B.S.C. (Alba) launched its month-long Breast Cancer Awareness Campaign on October 3, 2024, with an informative lecture by Dr. Fatema Hubail, Chief of Health Promotions Programs at the Ministry of Health. The session was held in-person for Alba’s female employees at the Oasis Hall and was also streamed live for all employees and their family members.

Dr. Abdulla Habib, the Chief Operations Officer, represented Alba’s senior management at the event, presenting a token of appreciation to Dr. Hubail on behalf of the company.

This Campaign aims to educate participants about breast cancer, covering its causes, diagnosis, prevention, and treatment. Throughout the month, various activities will be organized for Alba’s female employees, focusing on general and mental health, along with medical check-ups in partnership with the Ministry of Health and several private hospitals.

With a production capacity of 1.62 million metric tonnes per annum, Alba is a top aluminium smelter boasting a 50-year legacy of operational excellence, safety, and environmental responsibility. As a key player in Bahrain’s economy, Alba supplies high-quality aluminium to over 270 customers worldwide. With sales offices in Europe and Asia, and a subsidiary in the U.S., Alba is listed on the Bahrain Bourse and London Stock Exchange.

Share:

Related Insights

AstraZeneca commits $15 billion investment in China through 2030 to expand R&D and manufacturing

WellTheory launches postpartum program for women managing autoimmune symptoms after childbirth

King’s College London – Jeddah to Launch the First Saudi Conference on Gynecology and Fertility Tomorrow

Origin secures Series B funding to expand pelvic floor physical therapy access

Sword Health acquires Kaia Health in $285 million deal to expand in US and Germany

Wellspect HealthCare launches Surity™ Female External Catheter in the United States

Evaro secures $25 million series A to scale embedded healthcare platform in the UK

Aviva Bio receives FDA guidance on women’s testosterone therapy and reports new AVA-291 safety data